Publications by authors named "Elory Leonard"

Age is a risk factor for hematologic malignancies. Attributes of the aging hematopoietic system include increased myelopoiesis, impaired adaptive immunity, and a functional decline of the hematopoietic stem cells (HSCs) that maintain hematopoiesis. Changes in the composition of diverse HSC subsets have been suggested to be responsible for age-related alterations, however, the underlying regulatory mechanisms are incompletely understood in the context of HSC heterogeneity.

View Article and Find Full Text PDF

Traumatic or degenerative joint pain is abundant in the population. Symptom relief by intra- and periarticular glucocorticoid administration is frequently used, however may have potentially devastating effects, changing the normal healing process of the joint. Mesenchymal stem cells (MSCs) are important for wound-healing processes due to their multipotency in regenerating osteoblasts, chondrocytes and adipocytes but also have immunomodulatory properties.

View Article and Find Full Text PDF

Leukemia cutis or leukemic cell infiltration in skin is one of the common extramedullary manifestations of acute myeloid leukemia (AML) and signifies a poorer prognosis. However, its pathogenesis and maintenance remain understudied. Here, we report massive AML cell infiltration in the skin in a transplantation-induced MLL-AF9 AML mouse model.

View Article and Find Full Text PDF
Article Synopsis
  • Tyrosine kinase inhibitors (TKIs) are effective against chronic myeloid leukemia (CML) but do not eliminate leukemia-initiating stem cells (LSCs), leading to persistent disease and relapse.
  • The study investigates bone marrow (BM) niches in CML patients and finds differences in niche composition and function, revealing that mesenchymal stem cells from CML patients better support both normal and CML cells.
  • CXCL14 was identified as a key factor, as its loss in CML BM niches was linked to maintaining LSCs; restoring CXCL14 showed potential in inhibiting LSC growth and improving responses to TKIs like imatinib.
View Article and Find Full Text PDF